# ImmunityBio, Inc.: Form 8-K, filed Feb 15, 2022

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2022-02-15
- Accepted by EDGAR: Feb 15, 2022, 09:00 ET
- Period: 2022-02-14
- Accession: 0001193125-22-042967
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000119312522042967/d318218d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000119312522042967/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000119312522042967/d318218d8k.htm

Filed Feb 15, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-042967. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
